Pulsewave
Precision in Arterial Health Monitoring
Precision in Arterial Health Monitoring
PulseWave is a pioneering digital health care company with a focus on redefining the clinical diagnosis and long-term monitoring of arterial sclerosis. The company's innovative product, the TempleGuard, integrates a wearable biosensor seamlessly with the patient's eyeglasses, alongside cloud-based data analytics powered by proprietary algorithms. This unique combination distills data from millions of heartbeats into clinically actionable insights. Founded in 2020, PulseWave is confident that advancements in blood pressure monitoring and characterization could significantly impact how patients are clinically managed. The company recently secured a $120.00K Pre Seed Round investment on 14 September 2022 from Techstars. With its precise arterial health monitoring solutions, PulseWave is poised to make a significant impact in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $120.00K | 1 |
|
14 Sep 2022 |
| Grant | Fr.480.00K | 1 |
|
07 Jun 2022 |
| Pre Seed Round | Fr.260.00K | 1 |
|
14 Jan 2022 |
No recent news or press coverage available for Pulsewave.
We care about your data, and we'd love to use cookies make your experience better.
